D-1079-2020 Class II Terminated
FDA drug recall D-1079-2020 was initiated by Lupin Pharmaceuticals Inc. on April 1, 2020 and is designated Class II. Reason for recall: Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets. The recall status is terminated (terminated June 30, 2021). Affected quantity: 25,944 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- April 8, 2020
- Initiation Date
- April 1, 2020
- Termination Date
- June 30, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 25,944 bottles
Product Description
Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-982-01
Reason for Recall
Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.
Distribution Pattern
U.S.A. Nationwide
Code Information
Lot #: Q900580, Exp 9/2021